Loading clinical trials...
Loading clinical trials...
Eplerenone Observational Study Of Safety And Efficacy Evaluation To Normalize Blood Pressure For Clinical Effectiveness
To collect the efficacy and safety information of Eplerenone on patients with hypertension related to their appropriate use in daily practice.
Age
All ages
Sex
ALL
Healthy Volunteers
No
Start Date
June 1, 2008
Primary Completion Date
December 1, 2012
Completion Date
December 1, 2012
Last Updated
December 22, 2020
3,338
ACTUAL participants
Selara
DRUG
Lead Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions